Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Nutt

Showing results (141-150 of 389) with videos related to

Pageof 39
Sort By:
International Journal of Psychiatry in Clinical Practice|June 18, 2014
Cardiovascular reflexes during treatment of social phobia with moclobemideN J Coupland Caroline Bell John P Potokar Jayne E Bailey David J Nutt
Bjpsych Open|March 12, 2024
Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidenceMichael T Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 10, 2014
Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalizationDarren R Quelch, Loukia Katsouri, David J Nutt, et al.
Neuropharmacology|December 31, 2017
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depressionLeor Roseman, Lysia Demetriou, Matthew B Wall, et al.
Neuropharmacology|August 26, 2018
Psychedelics - Re-opening the doors of perceptionDavid J Heal, Jack Henningfield, Bruno G Frenguelli, et al.
Journal of Psychopharmacology (Oxford, England)|November 27, 2009
Harms associated with psychoactive substances: findings of the UK National Drug SurveyCelia J A Morgan, Leslie Muetzelfeldt, Mark Muetzelfeldt, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 24, 2025
The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trialJessica Henry, Bruna Giribaldi, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|May 12, 2016
A pilot study of the effect of short-term escitalopram treatment on brain metabolites and gamma-oscillations in healthy subjectsEduard Maron, Jamie Near, George Wallis, et al.
Scientific Reports|February 7, 2024
Effects of DMT on mental health outcomes in healthy volunteersChristopher Timmermann, Richard J Zeifman, David Erritzoe, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2010
Elucidation of neurobiology of anxiety disorders in children through pharmacological challenge tests and cortisol measurements: a systematic reviewBerta Garcia de Miguel, David J Nutt, Sean D Hood, et al.
Pageof 39

Showing results (141-150 of 389) with videos related to

Sort By:
Pageof 39
International Journal of Psychiatry in Clinical Practice|June 18, 2014
Cardiovascular reflexes during treatment of social phobia with moclobemideN J Coupland Caroline Bell John P Potokar Jayne E Bailey David J Nutt
Bjpsych Open|March 12, 2024
Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidenceMichael T Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 10, 2014
Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalizationDarren R Quelch, Loukia Katsouri, David J Nutt, et al.
Neuropharmacology|December 31, 2017
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depressionLeor Roseman, Lysia Demetriou, Matthew B Wall, et al.
Neuropharmacology|August 26, 2018
Psychedelics - Re-opening the doors of perceptionDavid J Heal, Jack Henningfield, Bruno G Frenguelli, et al.
Journal of Psychopharmacology (Oxford, England)|November 27, 2009
Harms associated with psychoactive substances: findings of the UK National Drug SurveyCelia J A Morgan, Leslie Muetzelfeldt, Mark Muetzelfeldt, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 24, 2025
The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trialJessica Henry, Bruna Giribaldi, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|May 12, 2016
A pilot study of the effect of short-term escitalopram treatment on brain metabolites and gamma-oscillations in healthy subjectsEduard Maron, Jamie Near, George Wallis, et al.
Scientific Reports|February 7, 2024
Effects of DMT on mental health outcomes in healthy volunteersChristopher Timmermann, Richard J Zeifman, David Erritzoe, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2010
Elucidation of neurobiology of anxiety disorders in children through pharmacological challenge tests and cortisol measurements: a systematic reviewBerta Garcia de Miguel, David J Nutt, Sean D Hood, et al.
Pageof 39